|
|
|
|
|
|
|
|
|
|
||||||
| | | | | | |
|
|
|
|
|||||
|
|
||||||
|
|
|
|
||||
|
|
|
|
New York, NY, August 13, 2003 -- Poseidon Sciences has completed the development of a safe,
environmentally-friendly, highly-effective product that can be added
to existing cosmetic formulations that prevent mosquitoes from
biting. This comes as U.S. health and local officials struggle
through another deadly outbreak this summer of the West Nile virus,
and an increase in the mosquito population following a long, wet
spring season. Protecting oneself against mosquito bites for as long
as you possibly can through the use of repellents remains one of the
best precautions. Poseidon’s MR
Technology is the result of over ten years of research on
repellents. Recent test results on MR Technology show the
enhancement of protection times of formulations containing DEET and
other natural products. This new material, referred to as MR-08
is a GRAS (generally regarded as safe) compound, which can be
formulated into a moisturizer, cream, spray or lotion to provide
protection times of up to eight hours. MR-08 also does not harm
clothes, plastics and synthetics it comes into contact with. Mosquito-borne diseases prevail throughout the world.
A vaccine against the West Nile virus, which killed 284 people in
the U.S. in 2002, is not expected in a few years. Malaria remains
one of the most infectious diseases in the less developed regions of
the world, killing more than one million persons a year; dengue
fever is five percent fatal among the millions that catch it
annually, while yellow fever claims more than 30,000 lives
worldwide. Poseidon Sciences is a company based in New York with
research facilities worldwide. It is engaged in discovering novel
technologies for applications in human health and the environment.
Among its recent innovations is a nontoxic antifouling additive to
prevent the attachment of fouling organisms such as barnacles and
algae on ships’ bottoms. Poseidon’s current research activities
include development of natural compounds for use in diabetes and
inflammation. For more information, please contact Jonathan R. Matias at (718)4545065, or jrmatias@poseidonsciences.com. Visit our website at www.poseidonsciences.com  Back to
NewsBack to top
|
|
© Copyright 2010, Poseidon Ocean Sciences, Inc. |